Ferenc Tracik
Chief Tech/Sci/R&D Officer chez NEUROSENSE THERAPEUTICS LTD.
Fortune : 223 771 $ au 31/03/2024
Profil
Ferenc Tracik's career history includes current and former positions as well as education.
Currently, he is the Chief Medical Officer at Neurosense Therapeutics Ltd.
Previously, he held the position of Managing Director-Germany Specialty Medicines at Teva Pharmaceutical Industries Ltd.
from 2013 to 2017.
From 2017 to 2020, he served as the VP-Medical Europe & Canada at Biogen, Inc. Additionally, he has worked as the Global Head-Medical at Orphazyme A.
In terms of education, Dr. Tracik holds doctorate degrees from Freie Universität Berlin and the University of Regensburg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 122 951 ( 0,90% ) | 223 771 $ | 31/03/2024 |
Postes actifs de Ferenc Tracik
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Anciens postes connus de Ferenc Tracik
| Sociétés | Poste | Fin |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/11/2020 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01/04/2017 |
| ORPHAZYME A/S | Corporate Officer/Principal | - |
Formation de Ferenc Tracik
| University of Regensburg | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BIOGEN INC. | Health Technology |
| ORPHAZYME A/S | Health Technology |
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
